Drug repurposing against COVID-19: focus on anticancer agents | Journal of Experimental & Clinical Cancer Research | Full Text

Drug repurposing against COVID-19: focus on anticancer agents | Journal of Experimental & Clinical Cancer Research | Full Text

Drug repurposing against COVID-19: focus on anticancer agents

The very limited time allowed to face the COVID-19 pandemic poses a pressing challenge to find proper therapeutic approaches. However, synthesis and full investigation from preclinical studies to phase III tri...

Authors:Gennaro Ciliberto, Rita Mancini and Marco G. Paggi

Citation:Journal of Experimental & Clinical Cancer Research 2020 39:86

Content type:Review

Published on: 12 May 2020

• ViewFull Text
 
• ViewPDF